Price alert —
Sign in to get a one-time email the moment SAN.PA crosses your price. Free accounts included.
Sign in / create a free accountSanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines.
SAN.PA last traded at $76.84, up 0.1% on the day; that's in the middle part of its 52-week range ($71.25–$84.04). Right now it's trading close to its recent average, with no strong stretch in either direction.
The next scheduled earnings report (2026-07-30) is the biggest known catalyst on the calendar, and day to day, watch whether it holds above or slips below its recent average.
A quick snapshot built from the data on this page — not investment advice. Always do your own research.
Price is stretched slightly above its normal range — a light stretch — early days, worth watching.
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · KC1 upper stretch — light pop
- · Aligned with weak downtrend
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
SAN.PA is a $91.4 billion company, priced at 19× last year's earnings, and it moves more calmly than the market (beta 0.3).
Earnings
See more →- Last reported
- 2026-04-23
- EPS (act / est)
- 1.88 / 1.80
- Surprise
- +4.5%
- Next report
- 2026-07-30
About
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that inclu…